Llwytho...
The restricted mean survival time as a replacement for the hazard ratio and the number needed to treat in long‐term studies
AIMS: We applied the restricted mean survival time (RMST) to analyse the survival data reported in the PARADIGM‐HT trial in which sacubitril + valsartan was studied in comparison with enalapril in patients with heart failure. The estimates of this parameter were compared with the published values of...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | ESC Heart Fail |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120383/ https://ncbi.nlm.nih.gov/pubmed/33733623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13306 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|